These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16341374)

  • 1. [Malignant neuroleptic syndrome and polyserositis associated to clozapine use: report of one case].
    Eymin G; Andresen M; Godoy J; Rada G
    Rev Med Chil; 2005 Oct; 133(10):1225-8. PubMed ID: 16341374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
    Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
    Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome and clozapine.
    Reddig S; Minnema AM; Tandon R
    Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetine.
    Gambassi G; Capurso S; Tarsitani P; Liperoti R; Bernabei R
    Aging Clin Exp Res; 2006 Jun; 18(3):266-70. PubMed ID: 16804375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent neuroleptic malignant syndrome with clozapine and lithium.
    Pope HG; Cole JO; Choras PT; Fulwiler CE
    J Nerv Ment Dis; 1986 Aug; 174(8):493-5. PubMed ID: 3090198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
    Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
    Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rechallenging clozapine after neuroleptic malignant syndrome.
    Anbalagan E; Ithman M; Lauriello J
    Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge.
    Huang TL
    Chang Gung Med J; 2001 Aug; 24(8):522-5. PubMed ID: 11601195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine.
    Paparrigopoulos T; Tzavellas E; Ferentinos P; Mourikis I; Liappas J
    World J Biol Psychiatry; 2009; 10(1):70-3. PubMed ID: 19673089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine withdrawal catatonia, psychosis and associated neuroleptic malignant syndrome.
    Ingole A; Bastiampillai T; Tibrewal P
    Asian J Psychiatr; 2017 Dec; 30():96-97. PubMed ID: 28846884
    [No Abstract]   [Full Text] [Related]  

  • 12. Confusion, Rigidity, and Elevated Creatine Phosphokinase: Atypical Neuroleptic Malignant Syndrome Possibly Associated With Clozapine and Sodium Valproate Use.
    Uvais NA; Moideen S; Anver PC
    Prim Care Companion CNS Disord; 2022 Sep; 24(5):. PubMed ID: 36179364
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine-induced peripheral and pleural fluid eosinophilia.
    Patel JJ; Lisi PA; Lathara Z; Lipchik RJ
    Ann Pharmacother; 2012 Feb; 46(2):e4. PubMed ID: 22274140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S; Buckley P
    Am J Psychiatry; 1998 Aug; 155(8):1113-6. PubMed ID: 9699705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature.
    Belteczki Z; Ujvari J; Dome P
    Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
    Musselman ME; Browning LA; Parker D; Saely S
    Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics and neuroleptic malignant syndrome.
    Velamoor VR
    Can J Psychiatry; 2001 Nov; 46(9):865-6. PubMed ID: 11761644
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine-induced neuroleptic malignant syndrome in an adolescent.
    Matheson KM; Gray G
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):322-4. PubMed ID: 22897669
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports].
    Vetter P; Proppe D; Hoppe-Seyler S
    Nervenarzt; 1991 Jan; 62(1):55-7. PubMed ID: 2027422
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
    Patel MK; Brunetti L
    Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.